Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Shareholder Alert: Robbins Arroyo LLP Reminds Investors the Lead Plaintiff Deadline is Approaching for Evolent Health, Inc. (EVH) Class Action

EVH

SAN DIEGO & ARLINGTON, Va.

Shareholder rights law firm Robbins Arroyo LLP reminds investors that a purchaser of Evolent Health, Inc. (NYSE: EVH) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between March 3, 2017 and May 28, 2019. Evolent Health provides health care delivery and payment solutions.

If you suffered a loss as a result of Evolent's misconduct, click here.

Evolent Health, Inc. (EVH) Accused of Misleading Shareholders

According to the complaint, Evolent touted a "land and expand" business model that increased revenues by securing health plan clients that were in impaired financial condition and offering them loans, equity investments, and other extensions of capital. Throughout the relevant period, Evolent assured investors that its strategy was to service health plans rather than own them, which would limit its financial exposure and avoid the political and financial risks faced by health plans. However, Evolent failed to disclose that its services extracted ever increasing fees from its clients, severely deteriorating their financial conditions. Then, on May 29, 2019, Evolent revealed that contrary to its business strategy, it would purchase a controlling interest in Passport, its largest client. Evolent disclosed that Passport was performing poorly due to inadequate management, despite the large management fees Passport was paying to Evolent. On this news, Evolent's stock price plummeted 30% and has since continued to decline, currently trading at around $7.90, an almost 73% decline from its class period high of $28.75.

If you purchased Evolent Health, Inc. (EVH) securities between March 3, 2017 and May 28, 2019, you have until October 7, 2019, to ask the court to be appointed lead plaintiff for the class.

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsarroyo.com
Shareholder Information Form

Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Leo Kandinov
Robbins Arroyo LLP
lkandinov@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com